NO20030587D0 - Fremgangsmåte til fremstilling av diskodermolid og analoger derav - Google Patents

Fremgangsmåte til fremstilling av diskodermolid og analoger derav

Info

Publication number
NO20030587D0
NO20030587D0 NO20030587A NO20030587A NO20030587D0 NO 20030587 D0 NO20030587 D0 NO 20030587D0 NO 20030587 A NO20030587 A NO 20030587A NO 20030587 A NO20030587 A NO 20030587A NO 20030587 D0 NO20030587 D0 NO 20030587D0
Authority
NO
Norway
Prior art keywords
discodermolide
analogs
preparation
Prior art date
Application number
NO20030587A
Other languages
English (en)
Other versions
NO20030587L (no
NO328365B1 (no
Inventor
Frederick Ray Kinder
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20030587D0 publication Critical patent/NO20030587D0/no
Publication of NO20030587L publication Critical patent/NO20030587L/no
Publication of NO328365B1 publication Critical patent/NO328365B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/12Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Pyrane Compounds (AREA)
NO20030587A 2000-08-07 2003-02-06 Fremgangsmate til fremstilling av diskodermolid og analoger derav NO328365B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63375300A 2000-08-07 2000-08-07
PCT/EP2001/009068 WO2002012220A2 (en) 2000-08-07 2001-08-06 Process for preparing discodermolide and analogues thereof

Publications (3)

Publication Number Publication Date
NO20030587D0 true NO20030587D0 (no) 2003-02-06
NO20030587L NO20030587L (no) 2003-02-06
NO328365B1 NO328365B1 (no) 2010-02-01

Family

ID=24540984

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030587A NO328365B1 (no) 2000-08-07 2003-02-06 Fremgangsmate til fremstilling av diskodermolid og analoger derav

Country Status (30)

Country Link
EP (1) EP1309583B1 (no)
JP (1) JP2004505963A (no)
KR (1) KR100796396B1 (no)
CN (1) CN1293067C (no)
AR (1) AR032761A1 (no)
AT (1) ATE330948T1 (no)
AU (2) AU9372601A (no)
BR (1) BR0112876A (no)
CA (1) CA2416769C (no)
CY (1) CY1105338T1 (no)
CZ (1) CZ300855B6 (no)
DE (1) DE60120991T2 (no)
DK (1) DK1309583T3 (no)
EC (1) ECSP034459A (no)
ES (1) ES2266266T3 (no)
HK (1) HK1055962A1 (no)
HU (1) HUP0300742A3 (no)
IL (2) IL154109A0 (no)
MX (1) MXPA03001192A (no)
MY (1) MY127609A (no)
NO (1) NO328365B1 (no)
NZ (1) NZ523999A (no)
PE (1) PE20020263A1 (no)
PL (1) PL358839A1 (no)
PT (1) PT1309583E (no)
RU (1) RU2283309C2 (no)
SK (1) SK1562003A3 (no)
TW (1) TWI251591B (no)
WO (1) WO2002012220A2 (no)
ZA (1) ZA200300590B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003251431A1 (en) * 2002-07-22 2004-02-09 Cambridge University Technical Services Ltd. Synthesis of discodermolide
US7321046B2 (en) 2002-09-06 2008-01-22 University Of Pittsburgh Analogs of dictyostatin, intermediates therefor and methods of synthesis thereof
AU2003263090A1 (en) * 2002-09-06 2004-03-29 University Of Pittsburgh Analogs of discodermolide and dictyostatin-1, intermediates therefor and methods of synthesis thereof
US7214708B2 (en) 2004-11-18 2007-05-08 Kosan Biosciences Incorporated Synthetic discodermolide analogs

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939168A (en) * 1989-08-11 1990-07-03 Harbor Branch Oceanographics Institution, Inc. Discodermolide compounds, compositions containing same and methods of preparation and use
GB9315802D0 (en) * 1993-07-30 1993-09-15 Roussel Lab Ltd Chemical compounds
US5789605A (en) * 1996-12-03 1998-08-04 Trustees Of The University Of Pennsylvania Synthetic techniques and intermediates for polyhydroxy, dienyl lactones and mimics thereof
US6096904A (en) * 1996-12-03 2000-08-01 The Trustees Of The University Of Pennsylvania Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives
WO1998048791A1 (en) * 1997-04-30 1998-11-05 The Regents Of The University Of California Synthesis of discodermolide and analogs
GB0101599D0 (en) * 2001-01-22 2001-03-07 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
NZ523999A (en) 2004-08-27
JP2004505963A (ja) 2004-02-26
EP1309583A2 (en) 2003-05-14
CN1446208A (zh) 2003-10-01
CZ2003330A3 (cs) 2003-05-14
WO2002012220A3 (en) 2002-06-13
CA2416769A1 (en) 2002-02-14
CY1105338T1 (el) 2010-03-03
IL154109A0 (en) 2003-07-31
DE60120991D1 (de) 2006-08-03
AR032761A1 (es) 2003-11-26
HK1055962A1 (en) 2004-01-30
MY127609A (en) 2006-12-29
PL358839A1 (en) 2004-08-23
MXPA03001192A (es) 2003-06-30
BR0112876A (pt) 2003-07-01
EP1309583B1 (en) 2006-06-21
ATE330948T1 (de) 2006-07-15
IL154109A (en) 2008-11-03
AU2001293726B2 (en) 2005-04-14
CN1293067C (zh) 2007-01-03
HUP0300742A3 (en) 2005-11-28
DE60120991T2 (de) 2007-06-21
RU2283309C2 (ru) 2006-09-10
PE20020263A1 (es) 2002-05-14
SK1562003A3 (en) 2003-08-05
NO20030587L (no) 2003-02-06
WO2002012220A2 (en) 2002-02-14
KR20030040385A (ko) 2003-05-22
KR100796396B1 (ko) 2008-01-21
TWI251591B (en) 2006-03-21
ECSP034459A (es) 2003-03-10
HUP0300742A2 (hu) 2003-09-29
CA2416769C (en) 2009-02-17
ES2266266T3 (es) 2007-03-01
CZ300855B6 (cs) 2009-08-26
DK1309583T3 (da) 2006-10-16
AU9372601A (en) 2002-02-18
NO328365B1 (no) 2010-02-01
ZA200300590B (en) 2004-04-01
PT1309583E (pt) 2006-10-31

Similar Documents

Publication Publication Date Title
NO20035162D0 (no) Fremgangsmåte for fremstilling av prostaglandiner og analoger derav
NO20030844D0 (no) Fremgangsmåte for fremstilling av N-aryl-antranilinsyrer og derivater derav
NO20030012L (no) Fremgangsmåte for fremstilling av substituerte oktanoylamider
CY2007029I1 (el) Μεθοδος για την παρασκευη υποκατεστημενων οκτανοϋλ-αμιδιων
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20054715L (no) Fremgangsmater og mellomprodukter for fremstilling av anti-cancer forbindelser
FI20011578A0 (fi) Menetelmä puhtaan sitalopraamin valmistamiseksi
FI20011621A (fi) Menetelmä sitalopraamin valmistamiseksi
NO20015542D0 (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
NO20040027L (no) Fremgangsmate for fremstillingen av escitalopram
NO20032440L (no) Fremgangsmåte for fremstillingen av iopamidol og de nye intermediater deri
NO20013735L (no) Fremgangsmåte til fremstilling av di-iso-butaner, di-iso- butener og di-n-butener fra feltbutaner
NO20025423L (no) Fremgangsmate for fremstilling av Citalopram
NO20021118D0 (no) Fremgangsmåte for fremstilling av citalopram
NO20030587L (no) Fremgangsmåte til fremstilling av diskodermolid og analoger derav
DK1339723T3 (da) Fremgangsmåde og ester derivater anvendelige til fremstilling af cefalosporiner
NO20030515D0 (no) Fremgangsmåte for fremstilling av dinapsolin
NO20012099D0 (no) Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser
NO20023577L (no) Fremgangsmåte for fremstilling av acetyl-amidinofenylalanyl- cykloheksylglycyl-pyridinioalaninamider
NO20033743D0 (no) Fremgangsmåte og fremstilling citalopram
NO20023702L (no) Fremgangsmåte for fremstilling av 5-arylnikotinaldehyder
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
DK0930297T3 (da) Fremgangsmåde til fremstilling af naphtyridoner og mellemprodukter
NO20020327D0 (no) Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol
PL339890A1 (en) Method of obtaining 4-chloro-n-(2-morpholinethyl)-benzamide

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees